107 related articles for article (PubMed ID: 27693945)
1. Repair genes expression profile of MLH1, MSH2 and ATM in the normal oral mucosa of chronic smokers.
Alves MG; Carta CF; de Barros PP; Issa JS; Nunes FD; Almeida JD
Arch Oral Biol; 2017 Jan; 73():60-65. PubMed ID: 27693945
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of mutS homolog 2 and mutL homolog 1 affects overall survival in laryngeal squamous cell carcinoma patients: Investigation into a potential cause.
Gong HL; Shi Y; Shi Y; Wu CP; Cao PY; Zhou L; Xu C
Oncol Rep; 2013 Sep; 30(3):1371-9. PubMed ID: 23787767
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.
Uehara H; Miyamoto M; Kato K; Cho Y; Kurokawa T; Murakami S; Fukunaga A; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
J Surg Oncol; 2005 Nov; 92(2):109-15. PubMed ID: 16231369
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers.
Lo YL; Hsiao CF; Jou YS; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hsieh WS; Chen CJ; Hsiung CA
Lung Cancer; 2011 Jun; 72(3):280-6. PubMed ID: 21093954
[TBL] [Abstract][Full Text] [Related]
5. The expression of MLH1 and MSH2 genes among inhabitants of high background radiation area of Ramsar, Iran.
Bakhtiari E; Monfared AS; Niaki HA; Borzoueisileh S; Niksirat F; Fattahi S; Monfared MK; Gorji KE
J Environ Radioact; 2019 Nov; 208-209():106012. PubMed ID: 31323602
[TBL] [Abstract][Full Text] [Related]
6. Expression of DNA repair genes in oral squamous cell carcinoma using reverse transcription-quantitative polymerase chain reaction.
Oliveira Alves MG; da Silva Miguel N; Ferreira CCP; Alvarenga ER; Tonon BM; de Barros PP; Carta CFL; Paschoal MBN; de Sales Chagas JF; Bandeira CM; Nunes FD; Almeida JD
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Sep; 130(3):298-305. PubMed ID: 32682592
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of DNA repair genes MLH1 and MSH2 in adenocarcinomas and squamous cell carcinomas of the lung.
Gomes A; Reis-Silva M; Alarcão A; Couceiro P; Sousa V; Carvalho L
Rev Port Pneumol; 2014; 20(1):20-30. PubMed ID: 24360395
[TBL] [Abstract][Full Text] [Related]
8. Expressional analysis of MLH1 and MSH2 in breast cancer.
Malik SS; Masood N; Asif M; Ahmed P; Shah ZU; Khan JS
Curr Probl Cancer; 2019 Apr; 43(2):97-105. PubMed ID: 30149959
[TBL] [Abstract][Full Text] [Related]
9. Genetic changes of MLH1 and MSH2 genes could explain constant findings on microsatellite instability in intracranial meningioma.
Pećina-Šlaus N; Kafka A; Bukovac A; Vladušić T; Tomas D; Hrašćan R
Tumour Biol; 2017 Jul; 39(7):1010428317705791. PubMed ID: 28705114
[TBL] [Abstract][Full Text] [Related]
10. Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer.
Grabsch H; Dattani M; Barker L; Maughan N; Maude K; Hansen O; Gabbert HE; Quirke P; Mueller W
Clin Cancer Res; 2006 Mar; 12(5):1494-500. PubMed ID: 16533773
[TBL] [Abstract][Full Text] [Related]
11. Association between promoter methylation of MLH1 and MSH2 and reactive oxygen species in oligozoospermic men-A pilot study.
Gunes S; Agarwal A; Henkel R; Mahmutoglu AM; Sharma R; Esteves SC; Aljowair A; Emirzeoglu D; Alkhani A; Pelegrini L; Joumah A; Sabanegh E
Andrologia; 2018 Apr; 50(3):. PubMed ID: 28983945
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of mismatch repair genes MLH1 and MSH2 is associated with chemotolerance of breast carcinoma: Clinical significance.
Dasgupta H; Islam S; Alam N; Roy A; Roychoudhury S; Panda CK
J Surg Oncol; 2019 Jan; 119(1):88-100. PubMed ID: 30481381
[TBL] [Abstract][Full Text] [Related]
13. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining.
Mangold E; Pagenstecher C; Friedl W; Fischer HP; Merkelbach-Bruse S; Ohlendorf M; Friedrichs N; Aretz S; Buettner R; Propping P; Mathiak M
J Pathol; 2005 Dec; 207(4):385-95. PubMed ID: 16216036
[TBL] [Abstract][Full Text] [Related]
14. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
J Oral Pathol Med; 2011 Mar; 40(3):218-26. PubMed ID: 21029181
[TBL] [Abstract][Full Text] [Related]
15. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK
Mol Cell Biochem; 2023 Jul; 478(7):1599-1610. PubMed ID: 36434146
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer.
Ewald J; Rodrigue CM; Mourra N; Lefèvre JH; Fléjou JF; Tiret E; Gespach C; Parc YR
Br J Surg; 2007 Aug; 94(8):1020-7. PubMed ID: 17440950
[TBL] [Abstract][Full Text] [Related]
17. Exonic deletions of mismatch repair genes MLH1 and MSH2 correlate with prognosis and protein expression levels in malignant melanomas.
Korabiowska M; Brinck U; Stachura J; Jawien J; Hasse FM; Cordon-Cardos C; Fischer G
Anticancer Res; 2006; 26(2A):1231-5. PubMed ID: 16619529
[TBL] [Abstract][Full Text] [Related]
18. Assessing how reduced expression levels of the mismatch repair genes MLH1, MSH2, and MSH6 affect repair efficiency.
Kansikas M; Kasela M; Kantelinen J; Nyström M
Hum Mutat; 2014 Sep; 35(9):1123-7. PubMed ID: 24924810
[TBL] [Abstract][Full Text] [Related]
19. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract][Full Text] [Related]
20. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
